Cargando…
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
MiR-223-3p is involved in the regulation of a broad range of cellular processes and in many types of pathological processes as cancer, autoimmune and inflammatory diseases. MiR-223-3p has been indicated as negative regulator of NLRP3 protein, a key protein of inflammasome. The chronic inflammasome a...
Autores principales: | Mancuso, Roberta, Agostini, Simone, Hernis, Ambra, Zanzottera, Milena, Bianchi, Anna, Clerici, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599033/ https://www.ncbi.nlm.nih.gov/pubmed/31253822 http://dx.doi.org/10.1038/s41598-019-45687-x |
Ejemplares similares
-
Serum and Exosomal miR-7-1-5p and miR-223-3p as Possible Biomarkers for Parkinson’s Disease
por: Citterio, Lorenzo Agostino, et al.
Publicado: (2023) -
Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer’s disease and amnestic mild cognitive impairment
por: Mancuso, Roberta, et al.
Publicado: (2014) -
Alterations of the miR-126-3p/POU2AF1/Spi-B Axis and JCPyV Reactivation in Multiple Sclerosis Patients Receiving Natalizumab
por: Mancuso, Roberta, et al.
Publicado: (2022) -
Activating KIR/HLA complexes in classic Kaposi's Sarcoma
por: Guerini, Franca R, et al.
Publicado: (2012) -
MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progression
por: Mancuso, Roberta, et al.
Publicado: (2015)